Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  Figures/Tables List
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Boccara, G.
space
  arrow  Guillon, G.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

LETTER

Secretion of Vasopressin from a Human Pheochromocytoma

right arrow Gilles Boccara, MD; Claude Mann, MD; and Gilles Guillon, MD

15 June 1998 | Volume 128 Issue 12 Part 1 | Page 1049


TO THE EDITOR:

A 12-year-old boy presented to the hospital with exertional dyspnea, resting tachycardia (heart rate, 180 beats/min), and hypertension (blood pressure, 220/110 mm Hg). Investigations showed a left para-aortic pheochromocytoma, and the patient was scheduled for surgical resection of the tumor.

Intraoperative manipulation of the tumor lead to hypertension; however, systolic blood pressure never exceeded 220 mm Hg, and heart rate never exceeded 100 beats/min because of treatment with a calcium-channel blocker and a ß1-adrenergic blocker. Plasma concentrations of catecholamine did not vary markedly, but the plasma level of arginine vasopressin did: The level was 220 pmol/L (normal, 0.4 to 4.0 pmol/L) during surgical manipulation and 26 pmol/L immediately after tumor resection (Table 1). Postoperative cytologic analysis confirmed a well-differentiated pheochromocytoma.


View this table:
[in this window]
[in a new window]
 
Table 1. Results of Blood Sampling Measurements during Tumor Manipulation and after Last Adrenal Vein Clamping

 

Immediately after resection, some tumor tissue was dissected into small pieces for measurement of the secretion rates of various hormones. In the absence of an exogenous secretagogue, arginine vasopressin was spontaneously secreted at a mean rate of 1.8 fmol/mL of perifusion eluate. The rate of arginine vasopressin secretion was increased 8000-fold during a corticotropin-releasing factor pulse and returned to baseline after the end of stimulation.

This is the first report of a human pheochromocytoma that secreted vasopressin. The intraoperative increase in the plasma level of arginine vasopressin and the moderate increase in adrenocorticotropin hormone level (Table 1) exclude the possibility that the release of arginine vasopressin was of pituitary origin. Moreover, secretion of arginine vasopressin from the pheochromocytoma was 2 times the basal secretion and 400 times the increase in corticotropin-releasing factor-stimulated release obtained from the normal medulla gland [1].

A high rate of arginine vasopressin secretion during surgical resection of pheochromocytoma may contribute to pheochromocytoma-induced hypertension [2], and hemodynamic changes induced by laparoscopic removal [3] have been related to vasopressin-induced vasoconstriction [4].


Author and Article Information
space
up arrowTop
dotAuthor & Article Info
down arrowReferences

Hospital St-Eloi; Montpellier, France


References
space
up arrowTop
up arrowAuthor & Article Info
dotReferences

1. Guillon G, Trueba M, Joubert D, Grazzini E, Chouinard L, Cote M, et al. Vasopressin stimulates steroid secretion in human adrenal glands: comparison with angiotensin II effect. Endocrinology. 1995; 136:1285-95.

2. Nussdorfer G. Paracrine control of adrenal cortical functions by medullary chromaffin cells. Pharmacol Rev. 1996; 48:495-530.

3. Mann C, Millat B, Boccara G, Atger J, Colson P. Tolerance of laparoscopy for resection of pheochromocytoma. Br J Anesth. 1996; 77:795-7.

4. Walder AD, Aitkenhead AR. Role of vasopressin in the haemodynamic response to laparoscopic cholecystectomy. Br J Anesth. 1997; 78:264-6.

About Letters
space

The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

•Include no more than 300 words of text, three authors, and five references

•Type with double-spacing

•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

Annals welcomes electronically submitted letters.





box Article
 arrow  Table of Contents                
space
 arrow  Figures/Tables List
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Boccara, G.
space
  arrow  Guillon, G.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space


 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online